. 2019 Mar;393(10177).
doi: 10.1016/S0140-6736(18)32552-2.

Epithelial ovarian cancer

Stephanie Lheureux 1 Charlie Gourley 2 Ignace Vergote 3 Amit M Oza 4 
  • PMID: 30910306
  •     136 citations


Epithelial ovarian cancer generally presents at an advanced stage and is the most common cause of gynaecological cancer death. Treatment requires expert multidisciplinary care. Population-based screening has been ineffective, but new approaches for early diagnosis and prevention that leverage molecular genomics are in development. Initial therapy includes surgery and adjuvant therapy. Epithelial ovarian cancer is composed of distinct histological subtypes with unique genomic characteristics, which are improving the precision and effectiveness of therapy, allowing discovery of predictors of response such as mutations in breast cancer susceptibility genes BRCA1 and BRCA2, and homologous recombination deficiency for DNA damage response pathway inhibitors or resistance (cyclin E1). Rapidly evolving techniques to measure genomic changes in tumour and blood allow for assessment of sensitivity and emergence of resistance to therapy, and might be accurate indicators of residual disease. Recurrence is usually incurable, and patient symptom control and quality of life are key considerations at this stage. Treatments for recurrence have to be designed from a patient's perspective and incorporate meaningful measures of benefit. Urgent progress is needed to develop evidence and consensus-based treatment guidelines for each subgroup, and requires close international cooperation in conducting clinical trials through academic research groups such as the Gynecologic Cancer Intergroup.

Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.
Matteo Dugo, Andrea Devecchi, +4 authors, Marina Bagnoli.
Genes (Basel), 2019 Sep 08; 10(9). PMID: 31491988    Free PMC article.
Multidrug resistance affects the prognosis of primary epithelial ovarian cancer.
Bo Gao, Fengmei Yang, +4 authors, Dongmin Li.
Oncol Lett, 2019 Oct 04; 18(4). PMID: 31579424    Free PMC article.
Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.
Koji Matsuo, Hiroko Machida, +7 authors, Mikio Mikami.
Obstet Gynecol, 2019 Oct 11; 134(5). PMID: 31599824    Free PMC article.
MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ.
Bo Yang, Li Sun, Lei Liang.
J Ovarian Res, 2019 Oct 24; 12(1). PMID: 31640760    Free PMC article.
ACTL6A regulates follicle-stimulating hormone-driven glycolysis in ovarian cancer cells via PGK1.
Jiawen Zhang, Jing Zhang, +2 authors, Qingying Wang.
Cell Death Dis, 2019 Oct 28; 10(11). PMID: 31649264    Free PMC article.
Poly-amino acids coated gold nanorod and doxorubicin for synergistic photodynamic therapy and chemotherapy in ovarian cancer cells.
JinYing Liu, Wei Ma, +3 authors, Jin Zhao.
Biosci Rep, 2019 Nov 20; 39(12). PMID: 31742323    Free PMC article.
A TAZ-ANGPTL4-NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer.
Wen-Hsuan Yang, Zhiqing Huang, +3 authors, Jen-Tsan Chi.
Mol Cancer Res, 2019 Oct 24; 18(1). PMID: 31641008    Free PMC article.
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors.
Ana Alcaraz-Sanabria, Mariona Baliu-Piqué, +9 authors, Alberto Ocana.
Front Oncol, 2020 Jan 31; 9. PMID: 31998644    Free PMC article.
TFRC promotes epithelial ovarian cancer cell proliferation and metastasis via up-regulation of AXIN2 expression.
Yake Huang, Jiani Huang, +4 authors, Rongkai Xie.
Am J Cancer Res, 2020 Feb 18; 10(1). PMID: 32064157    Free PMC article.
A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity.
Louisa Nelson, Anthony Tighe, +19 authors, Stephen S Taylor.
Nat Commun, 2020 Feb 15; 11(1). PMID: 32054838    Free PMC article.
Estrogen enhances the proliferation and migration of ovarian cancer cells by activating transient receptor potential channel C3.
Shengnan Li, Kuo Jiang, +6 authors, Biliang Chen.
J Ovarian Res, 2020 Feb 24; 13(1). PMID: 32087757    Free PMC article.
Onset of Telomere Dysfunction and Fusions in Human Ovarian Carcinoma.
Nazmul Huda, Yan Xu, +3 authors, David Gilley.
Cells, 2019 May 08; 8(5). PMID: 31060240    Free PMC article.
Preclinical Activity of Embryonic Annexin A2-Specific Chimeric Antigen Receptor T Cells Against Ovarian Cancer.
Leonard Leong, Heng Liang Tan, +3 authors, Andre Choo.
Int J Mol Sci, 2020 Jan 16; 21(2). PMID: 31936170    Free PMC article.
Plasma-activated Ringer's Lactate Solution Displays a Selective Cytotoxic Effect on Ovarian Cancer Cells.
Alina Bisag, Cristiana Bucci, +9 authors, Giuseppe Gasparre.
Cancers (Basel), 2020 Feb 23; 12(2). PMID: 32085609    Free PMC article.
MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2.
Xiaoxue Tian, Jianping Song, +9 authors, Zhaojian Liu.
Cell Death Dis, 2020 Mar 05; 11(3). PMID: 32127525    Free PMC article.
Functionalized Folate-Modified Graphene Oxide/PEI siRNA Nanocomplexes for Targeted Ovarian Cancer Gene Therapy.
Yunfei Wang, Guoping Sun, +3 authors, Linqing Yang.
Nanoscale Res Lett, 2020 Mar 07; 15(1). PMID: 32140846    Free PMC article.
Ovarian dysfunction following prenatal exposure to an insecticide, chlordecone, associates with altered epigenetic features.
Louis Legoff, Ouzna Dali, +9 authors, Fatima Smagulova.
Epigenetics Chromatin, 2019 May 16; 12(1). PMID: 31084621    Free PMC article.
Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
Junrong Wang, Weimin Ding, +7 authors, Xiuying Wu.
Aging (Albany NY), 2020 Mar 13; 12(5). PMID: 32163372    Free PMC article.
Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer.
Li-Yuan Feng, Li Li.
J Ovarian Res, 2020 Apr 02; 13(1). PMID: 32228639    Free PMC article.
Prophylactic salpingectomy for prevention of ovarian cancer at the time of elective laparoscopic cholecystectomy.
G Tomasch, M Lemmerer, +12 authors, K Tamussino.
Br J Surg, 2020 Mar 05; 107(5). PMID: 32129898    Free PMC article.
Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives.
Fulvio Borella, Eleonora Ghisoni, +4 authors, Dionyssios Katsaros.
Diagnostics (Basel), 2020 Mar 12; 10(3). PMID: 32156035    Free PMC article.
The role of the CDCA gene family in ovarian cancer.
Chongxiang Chen, Siliang Chen, +7 authors, Huan Li.
Ann Transl Med, 2020 Apr 21; 8(5). PMID: 32309337    Free PMC article.
Comparing Paclitaxel-Carboplatin with Paclitaxel-Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer.
Chen-Yu Huang, Min Cheng, +4 authors, Peng-Hui Wang.
Int J Environ Res Public Health, 2020 Apr 01; 17(7). PMID: 32224896    Free PMC article.
Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Rui Gou, Liancheng Zhu, +5 authors, Bei Lin.
J Transl Med, 2019 Sep 03; 17(1). PMID: 31474227    Free PMC article.
Expressions and clinical significances of STAT3 and Grim19 in epithelial ovarian cancer.
Yiru Wang, Ying Yan, Mengying Yang, Zhijun Yang.
3 Biotech, 2020 May 16; 10(6). PMID: 32411570    Free PMC article.
Activated CAMKKβ-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis.
Jeremi Laski, Bipradeb Singha, +3 authors, Trevor G Shepherd.
J Ovarian Res, 2020 May 13; 13(1). PMID: 32393385    Free PMC article.
The tubal epigenome - An emerging target for ovarian cancer.
Hunter D Reavis, Ronny Drapkin.
Pharmacol Ther, 2020 Mar 22; 210. PMID: 32197795    Free PMC article.
CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment.
Ying Zhu, Zhigang Zhang, +2 authors, Jianwei Zhou.
Front Genet, 2020 May 20; 11. PMID: 32425977    Free PMC article.
Non-canonical signaling pathway of SNAI2 induces EMT in ovarian cancer cells by suppressing miR-222-3p transcription and upregulating PDCD10.
Lili Fan, Han Lei, +4 authors, Gang Yin.
Theranostics, 2020 Jun 03; 10(13). PMID: 32483426    Free PMC article.
Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer.
Tzu-Ting Huang, Erika J Lampert, Cynthia Coots, Jung-Min Lee.
Cancer Treat Rev, 2020 Apr 21; 86. PMID: 32311593    Free PMC article.
Splicing factor proline- and glutamine-rich (SFPQ) protein regulates platinum response in ovarian cancer-modulating SRSF2 activity.
Ilenia Pellarin, Alessandra Dall'Acqua, +7 authors, Gustavo Baldassarre.
Oncogene, 2020 Apr 26; 39(22). PMID: 32332923    Free PMC article.
High expression of ZNF93 promotes proliferation and migration of ovarian cancer cells and relates to poor prognosis.
Xiao-Xiao Cui, Chen Zhou, +5 authors, Rong Zhang.
Int J Clin Exp Pathol, 2020 Jun 09; 13(5). PMID: 32509065    Free PMC article.
Identification of SOCS family members with prognostic values in human ovarian cancer.
Mengqi Yang, Huanting Chen, +3 authors, Peng Wang.
Am J Transl Res, 2020 Jun 09; 12(5). PMID: 32509179    Free PMC article.
The role of mitochondrial dynamics in human cancers.
Yawen Ma, Lihua Wang, Renbing Jia.
Am J Cancer Res, 2020 Jun 09; 10(5). PMID: 32509379    Free PMC article.
A novel role for NUAK1 in promoting ovarian cancer metastasis through regulation of fibronectin production in spheroids.
Jamie Lee Fritz, Olga Collins, +9 authors, Trevor G Shepherd.
Cancers (Basel), 2020 May 21; 12(5). PMID: 32429240    Free PMC article.
Subsequent Development of Epithelial Ovarian Cancer After Ovarian Surgery for Benign Ovarian Tumor: A Population-Based Cohort Study.
Chen-Yu Huang, Wen-Hsun Chang, +5 authors, Peng-Hui Wang.
Clin Epidemiol, 2020 Jul 02; 12. PMID: 32606989    Free PMC article.
Cul4B promotes the progression of ovarian cancer by upregulating the expression of CDK2 and CyclinD1.
Peng-Jing Duan, Juan-Hong Zhao, Li-Li Xie.
J Ovarian Res, 2020 Jul 06; 13(1). PMID: 32622365    Free PMC article.
Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer.
Michelle McMullen, Katherine Karakasis, Ainhoa Madariaga, Amit M Oza.
Cancers (Basel), 2020 Jun 21; 12(6). PMID: 32560564    Free PMC article.
Epithelial-mesenchymal interconversions in ovarian cancer: The levels and functions of E-cadherin in intraabdominal dissemination.
Ricardo Roque, Filipa Costa Sousa, Margarida Figueiredo-Dias.
Oncol Rev, 2020 Jul 18; 14(2). PMID: 32676171    Free PMC article.
circRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382-5p/PRPF8 axis.
Qin Xu, Bo Deng, +2 authors, Li Zhuan.
J Ovarian Res, 2020 Jul 22; 13(1). PMID: 32690086    Free PMC article.
Clinical Implications of Circulating Tumor DNA from Ascites and Serial Plasma in Ovarian Cancer.
Mi-Ryung Han, Sug Hyung Lee, +4 authors, Youn Jin Choi.
Cancer Res Treat, 2020 Feb 29; 52(3). PMID: 32106643    Free PMC article.
Integrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer.
Anqi Wu, Sai Zhang, +4 authors, Gang Yin.
Front Genet, 2020 Aug 09; 11. PMID: 32765584    Free PMC article.
High neuropilin and tolloid-like 1 expression associated with metastasis and poor survival in epithelial ovarian cancer via regulation of actin cytoskeleton.
Yunzhao Xu, Wei Wang, +6 authors, Wenyu Shi.
J Cell Mol Med, 2020 Jul 09; 24(16). PMID: 32638511    Free PMC article.
Perspectives on molecular signaling in cancer and update on therapeutic options for the treatment of metastatic cancer.
Khalid Sossey-Alaoui.
Ann Transl Med, 2020 Aug 15; 8(14). PMID: 32793743    Free PMC article.
Signaling within the epithelial ovarian cancer tumor microenvironment: the challenge of tumor heterogeneity.
Max Horowitz, Emily Esakov, Peter Rose, Ofer Reizes.
Ann Transl Med, 2020 Aug 15; 8(14). PMID: 32793749    Free PMC article.
Identification of a Novel Prognostic Classification Model in Epithelial Ovarian Cancer by Cluster Analysis.
Kelie Chen, Yuequn Niu, +9 authors, Weiguo Lu.
Cancer Manag Res, 2020 Aug 18; 12. PMID: 32801870    Free PMC article.
Eukaryotic initiation factor 3B is overexpressed and correlates with larger tumor size, advanced FIGO stage, and shorter overall survival in epithelial ovarian cancer patients.
Nannan Zhao, Yanjuan Guo, +2 authors, Jun Xing.
J Clin Lab Anal, 2020 May 19; 34(8). PMID: 32419232    Free PMC article.
Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells.
Yanwei Luo, Rong Gui.
J Gynecol Oncol, 2020 Aug 19; 31(5). PMID: 32808501    Free PMC article.
The Biological and Clinical Role of the Long Non-Coding RNA LOC642852 in Ovarian Carcinoma.
Natalie Filippov-Levy, Reuven Reich, Ben Davidson.
Int J Mol Sci, 2020 Jul 29; 21(15). PMID: 32718068    Free PMC article.
Evaluation of Ovarian Tumors with Multidetector Computed Tomography and Tumor Markers: Differentiation of Stage I Serous Borderline Tumors and Stage I Serous Malignant Tumors Presenting as Solid-Cystic Mass.
Xin-Ping Yu, Ying Liu, +3 authors, Shuai Zhang.
Med Sci Monit, 2020 Aug 18; 26. PMID: 32801292    Free PMC article.
Knockdown of ribosomal protein S6 suppresses proliferation, migration, and invasion in epithelial ovarian cancer.
Xueqing Yang, Luxi Xu, +4 authors, Yaying Lin.
J Ovarian Res, 2020 Aug 31; 13(1). PMID: 32862831    Free PMC article.
Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis.
Fulvio Borella, Luca Bertero, +11 authors, Chiara Benedetto.
Cancers (Basel), 2020 Aug 08; 12(8). PMID: 32759682    Free PMC article.
Modeling the Diversity of Epithelial Ovarian Cancer through Ten Novel Well Characterized Cell Lines Covering Multiple Subtypes of the Disease.
Alexandre Sauriol, Kayla Simeone, +9 authors, Anne-Marie Mes-Masson.
Cancers (Basel), 2020 Aug 14; 12(8). PMID: 32784519    Free PMC article.
Antibody-Drug Conjugates: A Promising Novel Therapy for the Treatment of Ovarian Cancer.
Aranzazu Manzano, Alberto Ocaña.
Cancers (Basel), 2020 Aug 14; 12(8). PMID: 32784819    Free PMC article.
The Natural Product Fucoidan Inhibits Proliferation and Induces Apoptosis of Human Ovarian Cancer Cells: Focus on the PI3K/Akt Signaling Pathway.
Shuhan Liu, Jing Yang, +2 authors, Cunjing Zhu.
Cancer Manag Res, 2020 Sep 05; 12. PMID: 32884336    Free PMC article.
Different mechanisms underlie IL-6 release in chemosensitive and chemoresistant ovarian carcinoma cells.
Margot De Marco, Antonia Falco, +17 authors, Liberato Marzullo.
Am J Cancer Res, 2020 Sep 10; 10(8). PMID: 32905525    Free PMC article.
Rare Distant Metastatic Disease of Ovarian and Peritoneal Carcinomatosis: A Review of the Literature.
Nikolaos Thomakos, Michail Diakosavvas, +3 authors, Alexandros Rodolakis.
Cancers (Basel), 2019 Jul 28; 11(8). PMID: 31344859    Free PMC article.
Identification of clinical trait-related lncRNA and mRNA biomarkers with weighted gene co-expression network analysis as useful tool for personalized medicine in ovarian cancer.
Na Li, Xianquan Zhan.
EPMA J, 2019 Aug 30; 10(3). PMID: 31462944    Free PMC article.
Evolving population-based statistics for rare epithelial ovarian cancers.
Koji Matsuo, Hiroko Machida, +6 authors, Jason D Wright.
Gynecol Oncol, 2020 Jan 20; 157(1). PMID: 31954534    Free PMC article.
MicroRNA‑195 suppresses cell proliferation, migration and invasion in epithelial ovarian carcinoma via inhibition of the CDC42/CCND1 pathway.
Xiaoying Hao, Qingqing Jia, +4 authors, Ye Guo.
Int J Mol Med, 2020 Sep 10; 46(5). PMID: 32901852    Free PMC article.
The clinical impact of intra- and extracellular miRNAs in ovarian cancer.
Kosuke Yoshida, Akira Yokoi, +2 authors, Yusuke Yamamoto.
Cancer Sci, 2020 Aug 05; 111(10). PMID: 32750177    Free PMC article.
Detection of MCM5 as a novel non-invasive aid for the diagnosis of endometrial and ovarian tumours.
J Stockley, R Akhand, +3 authors, R J Edmondson.
BMC Cancer, 2020 Oct 17; 20(1). PMID: 33059604    Free PMC article.
Ferroptosis of epithelial ovarian cancer: genetic determinants and therapeutic potential.
Chao-Chieh Lin, Jen-Tsan Chi.
Oncotarget, 2020 Oct 17; 11(39). PMID: 33062192    Free PMC article.
Long non-coding RNA PTPRG-AS1 promotes cell tumorigenicity in epithelial ovarian cancer by decoying microRNA-545-3p and consequently enhancing HDAC4 expression.
Juanjuan Shi, Xijian Xu, +7 authors, Peishu Liu.
J Ovarian Res, 2020 Oct 26; 13(1). PMID: 33099316    Free PMC article.
Mainstreaming germline BRCA1/2 testing in non-mucinous epithelial ovarian cancer in the North West of England.
Nicola Flaum, Robert D Morgan, +18 authors, D Gareth R Evans.
Eur J Hum Genet, 2020 Jul 12; 28(11). PMID: 32651552    Free PMC article.
Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer.
Marina Pavanello, Isaac Hy Chan, +3 authors, Susan J Ramus.
Cancers (Basel), 2020 Oct 23; 12(10). PMID: 33086730    Free PMC article.
High-throughput approaches for precision medicine in high-grade serous ovarian cancer.
Meinusha Govindarajan, Christoph Wohlmuth, +2 authors, Thomas Kislinger.
J Hematol Oncol, 2020 Oct 11; 13(1). PMID: 33036656    Free PMC article.
Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-type Lectin (MGL).
Chiara Napoletano, Catharina Steentoff, +13 authors, Aurelia Rughetti.
Cancers (Basel), 2020 Oct 07; 12(10). PMID: 33019700    Free PMC article.
The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas.
Lise M van Wijk, Sylvia Vermeulen, +11 authors, Maaike P G Vreeswijk.
Cancers (Basel), 2020 Oct 03; 12(10). PMID: 33003546    Free PMC article.
Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.
Mariana Nunes, Miguel Henriques Abreu, Carla Bartosch, Sara Ricardo.
Int J Mol Sci, 2020 Oct 24; 21(20). PMID: 33092251    Free PMC article.
LncRNA MALAT1 Promotes Survival of Epithelial Ovarian Cancer Cells by Downregulating miR-145-5p.
Ke Wang, Ye Zhao, Yi-Min Wang.
Cancer Manag Res, 2020 Nov 17; 12. PMID: 33192095    Free PMC article.
LRH1 Promotes Tumor Cell Proliferation and Migration and Is Correlated With Poor Prognosis in Ovarian Cancer.
Wenzhou Sun, Qingtao Shi, +2 authors, Libo Yu.
Front Oncol, 2020 Nov 17; 10. PMID: 33194722    Free PMC article.
DUETTE: a phase II randomized, multicenter study to investigate the efficacy and tolerability of a second maintenance treatment in patients with platinum-sensitive relapsed epithelial ovarian cancer, who have previously received poly(ADP-ribose) polymerase (PARP) inhibitor maintenance treatment.
Michelle McMullen, Katherine Karakasis, +3 authors, Amit M Oza.
Int J Gynecol Cancer, 2020 Sep 04; 30(11). PMID: 32878963    Free PMC article.
Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA.
Shuzhen Zhao, Xinlei Guan, +4 authors, Caihong Hua.
Ann Transl Med, 2020 Nov 27; 8(18). PMID: 33240988    Free PMC article.
Immune Checkpoint Blockade in Gynecologic Cancers: State of Affairs.
Maureen L Drakes, Cheryl M Czerlanis, Patrick J Stiff.
Cancers (Basel), 2020 Nov 14; 12(11). PMID: 33182298    Free PMC article.
Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Antoine El Asmar, Melissa Bendavides, +5 authors, Gabriel Liberale.
World J Surg Oncol, 2020 Nov 28; 18(1). PMID: 33243287    Free PMC article.
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
Stephen P Hack, Andrew X Zhu, Yulei Wang.
Front Immunol, 2020 Dec 01; 11. PMID: 33250900    Free PMC article.
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines.
Lorena Losi, Angela Lauriola, +4 authors, Jean Benhattar.
J Ovarian Res, 2019 Jul 12; 12(1). PMID: 31291979    Free PMC article.
Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach.
Piera Tocci, Laura Rosanò, Anna Bagnato.
Front Endocrinol (Lausanne), 2019 Sep 26; 10. PMID: 31551935    Free PMC article.
Targeting the PI3K/mTOR Pathway Augments CHK1 Inhibitor-Induced Replication Stress and Antitumor Activity in High-Grade Serous Ovarian Cancer.
Tzu-Ting Huang, Ethan Brill, +5 authors, Jung-Min Lee.
Cancer Res, 2020 Oct 02; 80(23). PMID: 32998994    Free PMC article.
Construction of a new tumor immunity-related signature to assess and classify the prognostic risk of ovarian cancer.
Jiashan Ding, Qiaoling Zhang, +2 authors, Linsheng He.
Aging (Albany NY), 2020 Nov 07; 12(21). PMID: 33154188    Free PMC article.
Development of Therapeutic Vaccines for Ovarian Cancer.
Stephanie Chow, Jonathan S Berek, Oliver Dorigo.
Vaccines (Basel), 2020 Nov 11; 8(4). PMID: 33167428    Free PMC article.
KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer.
Marta De Donato, Gabriele Babini, +6 authors, Daniela Gallo.
J Exp Clin Cancer Res, 2020 Dec 01; 39(1). PMID: 33250051    Free PMC article.
The Emerging Role of CD24 in Cancer Theranostics-A Novel Target for Fluorescence Image-Guided Surgery in Ovarian Cancer and Beyond.
Katrin Kleinmanns, Vibeke Fosse, Line Bjørge, Emmet McCormack.
J Pers Med, 2020 Dec 03; 10(4). PMID: 33260974    Free PMC article.
Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling.
Yousheng Wei, Tingyu Ou, +4 authors, Desheng Yao.
PeerJ, 2020 Dec 08; 8. PMID: 33282564    Free PMC article.
LncRNA SNHG3, a potential oncogene in human cancers.
Bin Xu, Jie Mei, +4 authors, Junfei Shao.
Cancer Cell Int, 2020 Dec 10; 20(1). PMID: 33292213    Free PMC article.
MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
Shuhua Zhao, Xiaohong Zhang, +5 authors, Hong Yang.
J Exp Clin Cancer Res, 2020 Dec 16; 39(1). PMID: 33317572    Free PMC article.
MR image-based radiomics to differentiate type Ι and type ΙΙ epithelial ovarian cancers.
Junming Jian, Yong'ai Li, +16 authors, Jinwei Qiang.
Eur Radiol, 2020 Aug 04; 31(1). PMID: 32743768
Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies.
Aleksandra Klemba, Lubomir Bodnar, +4 authors, Claudine Kieda.
Int J Mol Sci, 2020 Dec 18; 21(24). PMID: 33327450    Free PMC article.
Molecular Alterations in Metastatic Ovarian Cancer From Gastrointestinal Cancer.
Chao Chen, Xiaoxu Ge, +6 authors, Lifeng Sun.
Front Oncol, 2020 Dec 29; 10. PMID: 33363035    Free PMC article.
Prognostic value of microRNA-21 in epithelial ovarian carcinoma: A protocol for systematic review and meta analysis.
Kun Ji, Xiaohua Wang, Anqi Zhang, Hongwei Wen.
Medicine (Baltimore), 2020 Dec 23; 99(52). PMID: 33350775    Free PMC article.
Choline kinase alpha impairment overcomes TRAIL resistance in ovarian cancer cells.
Andrea Rizzo, Alessandro Satta, +9 authors, Marina Bagnoli.
J Exp Clin Cancer Res, 2021 Jan 05; 40(1). PMID: 33390181    Free PMC article.
Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer.
Jiawen Zhang, Yunfei Chen, +9 authors, Lan Fang.
Cell Death Differ, 2020 Jul 18; 28(1). PMID: 32678307    Free PMC article.
Reflections on the Role of Malat1 in Gynecological Cancer.
Huiyan Liao, Qi Chen, Jing Xiao.
Cancer Manag Res, 2021 Jan 08; 12. PMID: 33408521    Free PMC article.
Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems.
Bishnubrata Patra, Muhammad Abdul Lateef, +6 authors, Thomas Gervais.
PLoS One, 2021 Jan 01; 15(12). PMID: 33382759    Free PMC article.
Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer.
Akbar Satria Fitriawan, Aprilia Indra Kartika, +2 authors, Sofia Mubarika Haryana.
Malays J Med Sci, 2021 Jan 16; 27(6). PMID: 33447132    Free PMC article.
LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via miR-455-5p and miR-491-5p sponging.
Jian Cao, Huan Wang, +7 authors, Suping Han.
J Cell Mol Med, 2020 Dec 21; 25(2). PMID: 33342041    Free PMC article.
MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors.
Xin-Ping Yu, Lei Wang, +5 authors, Shuai Zhang.
Cancer Manag Res, 2021 Jan 26; 13. PMID: 33488120    Free PMC article.
Current practices on genetic testing in ovarian cancer.
Florentia Fostira, Marios Papadimitriou, Christos Papadimitriou.
Ann Transl Med, 2021 Jan 26; 8(24). PMID: 33490215    Free PMC article.
Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review.
Eleftherios P Samartzis, S Intidhar Labidi-Galy, +4 authors, Stergios Boussios.
Ann Transl Med, 2021 Jan 26; 8(24). PMID: 33490224    Free PMC article.
miR-362-3p acts as a tumor suppressor by targeting SERBP1 in ovarian cancer.
Shujun Cao, Na Li, Xihong Liao.
J Ovarian Res, 2021 Feb 03; 14(1). PMID: 33526047    Free PMC article.
Identification of the Hub Genes Associated with the Prognosis of Ovarian Cancer Patients via Integrated Bioinformatics Analysis and Experimental Validation.
Yuzi Zhao, Jie Pi, +3 authors, Li Hong.
Cancer Manag Res, 2021 Feb 06; 13. PMID: 33542655    Free PMC article.
Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker.
Sophie Liot, Alexandre Aubert, +5 authors, Elise Lambert.
Matrix Biol Plus, 2021 Feb 06; 6-7. PMID: 33543019    Free PMC article.
A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin.
Dengxuan Fan, Hailing Yang, +7 authors, Zhen Lu.
Cancers (Basel), 2021 Jan 29; 13(3). PMID: 33503955    Free PMC article.
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin.
Tatiana V Gorodnova, Anna P Sokolenko, +7 authors, Evgeny N Imyanitov.
Hered Cancer Clin Pract, 2021 Feb 05; 19(1). PMID: 33536037    Free PMC article.
Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer.
Chaofan He, Fuxin Huang, +3 authors, Meng Liang.
J Ovarian Res, 2021 Feb 09; 14(1). PMID: 33550985    Free PMC article.
Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexa.
Laudine Communal, Mauricio Medrano, +11 authors, Anne-Marie Mes-Masson.
Mod Pathol, 2020 Jun 10; 33(11). PMID: 32514162
MicroRNA-377-3p targeting MMP-16 inhibits ovarian cancer cell growth, invasion, and interstitial transition.
Huabin Wang, Changmin Qi, Dan Wan.
Ann Transl Med, 2021 Feb 12; 9(2). PMID: 33569426    Free PMC article.
A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients with Advanced Extrauterine High-Grade Serous Carcinoma after Neoadjuvant Chemotherapy.
Yanping Zhong, Jinsong Liu, +8 authors, Nicole D Fleming.
Cancers (Basel), 2021 Feb 13; 13(4). PMID: 33572451    Free PMC article.
The use of neoadjuvant chemotherapy in advanced endometrial cancer.
L Philp, A Kanbergs, +3 authors, A Goodman.
Gynecol Oncol Rep, 2021 Mar 02; 36. PMID: 33644284    Free PMC article.
Identification of LncRNA Prognostic Markers for Ovarian Cancer by Integration of Co-expression and CeRNA Network.
Huisheng Liang, Yuquan Bai, Hailong Wang, Xiangjun Yang.
Front Genet, 2021 Mar 06; 11. PMID: 33664764    Free PMC article.
Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer.
Jun Wu, Quan Wang, +10 authors, Jun Dai.
Theranostics, 2021 Mar 06; 11(8). PMID: 33664857    Free PMC article.
A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate.
Xiaofeng Qiu, Dongxia Guo, +2 authors, Fengying Wang.
Medicine (Baltimore), 2021 Mar 06; 100(8). PMID: 33663122    Free PMC article.
Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis.
Beata Gąsowska-Bajger, Agnieszka Gąsowska-Bodnar, Paweł Knapp, Lubomir Bodnar.
J Clin Med, 2021 Mar 07; 10(4). PMID: 33669912    Free PMC article.
Long non‑coding RNA ASAP1‑IT1 suppresses ovarian cancer progression by regulating Hippo/YAP signaling.
Ke Wang, Yu-Bo Hu, Ye Zhao, Cong Ye.
Int J Mol Med, 2021 Feb 13; 47(4). PMID: 33576454    Free PMC article.
Development and Validation of an Immune-Related Gene-Pair Model of High-Grade Serous Ovarian Cancer After Platinum-Based Chemotherapy.
Jiaxing Lin, Xiao Xu, Dan Sun, Tianren Li.
Front Oncol, 2021 Mar 09; 10. PMID: 33680950    Free PMC article.
Construction autophagy-related prognostic risk signature to facilitate survival prediction, individual treatment and biomarker excavation of epithelial ovarian cancer patients.
Hongjun Fei, Songchang Chen, Chenming Xu.
J Ovarian Res, 2021 Mar 08; 14(1). PMID: 33676525    Free PMC article.
Enhancing delivery of small molecule and cell-based therapies for ovarian cancer using advanced delivery strategies.
Joanne O'Dwyer, Roisin E O'Cearbhaill, +4 authors, Eimear B Dolan.
Adv Ther (Weinh), 2021 Mar 13; 3(11). PMID: 33709016    Free PMC article.
Deregulation of angiopoietin-like 4 slows ovarian cancer progression through vascular endothelial growth factor receptor 2 phosphorylation.
Yuxian Wu, Jinghai Gao, Xiaojun Liu.
Cancer Cell Int, 2021 Mar 18; 21(1). PMID: 33726754    Free PMC article.
SIRT1 and gynecological malignancies (Review).
Jiayu Chen, Houzao Chen, Lingya Pan.
Oncol Rep, 2021 Mar 03; 45(4). PMID: 33649834    Free PMC article.
Clinicopathological and immunological characterization of RNA m6 A methylation regulators in ovarian cancer.
Qingying Wang, Qinyi Zhang, +2 authors, Jiawen Zhang.
Mol Genet Genomic Med, 2020 Nov 24; 9(1). PMID: 33225598    Free PMC article.
Comparison of the survival outcomes of laparoscopy versus laparotomy in treatment of early-stage ovarian cancer: a systematic review and meta-analysis.
Qingduo Kong, Hongyi Wei, +2 authors, Yongjun Wang.
J Ovarian Res, 2021 Mar 18; 14(1). PMID: 33726795    Free PMC article.
Circular RNA ABCB10 promotes cell proliferation and invasion, but inhibits apoptosis via regulating the microRNA‑1271‑mediated Capn4/Wnt/β‑catenin signaling pathway in epithelial ovarian cancer.
Xuefang Lin, Yan Chen, Xiabin Ye, Xuemei Xia.
Mol Med Rep, 2021 Mar 25; 23(5). PMID: 33760208    Free PMC article.
OPCML Methylation and the Risk of Ovarian Cancer: A Meta and Bioinformatics Analysis.
Yang Shao, Jing Kong, +7 authors, Jiangping Wu.
Front Cell Dev Biol, 2021 Mar 30; 9. PMID: 33777925    Free PMC article.
Systematic Review.
Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications.
Miner Yang, Gaowen Chen, Kunjie Gao, Yifeng Wang.
Front Oncol, 2021 Apr 03; 11. PMID: 33796460    Free PMC article.
Preclinical Verification of the Efficacy and Safety of Aqueous Plasma for Ovarian Cancer Therapy.
Kae Nakamura, Nobuhisa Yoshikawa, +7 authors, Hiroaki Kajiyama.
Cancers (Basel), 2021 Apr 04; 13(5). PMID: 33799991    Free PMC article.
The Role of Myeloid-Derived Suppressor Cells (MDSCs) in the Development and/or Progression of Endometriosis-State of the Art.
Dorota Suszczyk, Wiktoria Skiba, +2 authors, Iwona Wertel.
Cells, 2021 Apr 04; 10(3). PMID: 33803806    Free PMC article.
Low Expression of Circular RNA hsa_circ_0078607 Predicts Poor Prognosis in High-Grade Serous Ovarian Cancer.
Nan Zhang, Zhiyou Yang, +3 authors, Yu Wang.
Cancer Manag Res, 2021 Apr 10; 13. PMID: 33833570    Free PMC article.
Triptolide inhibits JAK2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
Yanying Zhong, Fuyin Le, +6 authors, Buzhen Tan.
Oncol Rep, 2021 Mar 25; 45(5). PMID: 33760192    Free PMC article.
Prognostic Evidence of the miRNA-Based Ovarian Cancer Signature MiROvaR in Independent Datasets.
Loris De Cecco, Marina Bagnoli, +2 authors, Delia Mezzanzanica.
Cancers (Basel), 2021 Apr 04; 13(7). PMID: 33801595    Free PMC article.
HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.
Rita Lombardi, Maura Sonego, +12 authors, Alfredo Budillon.
Mol Oncol, 2020 Dec 18; 15(4). PMID: 33331136    Free PMC article.
Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2.
Shourong Wang, Zixiang Wang, +9 authors, Zhaojian Liu.
Cell Death Dis, 2021 Mar 19; 12(4). PMID: 33731694    Free PMC article.
Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
Guangwei Wang, Xiaofei Liu, +2 authors, Qing Yang.
Front Oncol, 2021 Apr 13; 11. PMID: 33842342    Free PMC article.
ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer.
Wenlong Feng, Dylan C Dean, +4 authors, Huirong Shi.
Ther Adv Med Oncol, 2021 Apr 16; 12. PMID: 33854565    Free PMC article.
Utility of Preoperative Inflammatory Markers to Distinguish Epithelial Ovarian Cancer from Benign Ovarian Masses.
Lian Li, Jing Tian, +6 authors, Kexin Chen.
J Cancer, 2021 Apr 16; 12(9). PMID: 33854628    Free PMC article.
A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer.
Ying Ye, Qinjin Dai, +2 authors, Hongbo Qi.
Front Mol Biosci, 2021 Apr 20; 8. PMID: 33869286    Free PMC article.